Bristol-Myers Squibb (BMY)
59.50
-1.49 (-2.44%)
At close: Apr 01, 2025, 3:59 PM
59.59
0.14%
Pre-market: Apr 02, 2025, 04:35 AM EDT
Abecma Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | 132M | -15M | -10.20% |
| Mar 31, 2023 | 147M | 22M | +17.60% |
| Dec 31, 2022 | 125M | 18M | +16.82% |
| Sep 30, 2022 | 107M | 18M | +20.22% |
| Jun 30, 2022 | 89M | 22M | +32.84% |
| Mar 31, 2022 | 67M | -2M | -2.90% |
| Dec 31, 2021 | 69M | -2M | -2.82% |
| Sep 30, 2021 | 71M | 47M | +195.83% |
| Jun 30, 2021 | 24M | -290M | -92.36% |
| Mar 31, 2021 | 314M | 17M | +5.72% |
| Dec 31, 2020 | 297M | -45M | -13.16% |
| Sep 30, 2020 | 342M | 34M | +11.04% |
| Jun 30, 2020 | 308M | 8M | +2.67% |
| Mar 31, 2020 | 300M | -1.73B | -85.25% |
| Dec 31, 2019 | 2.03B | 106M | +5.50% |
| Sep 30, 2019 | 1.93B | -114M | -5.58% |
| Jun 30, 2019 | 2.04B | 117M | +6.08% |
| Mar 31, 2019 | 1.93B | 220M | +12.90% |
| Dec 31, 2018 | 1.71B | 128M | +8.12% |
| Sep 30, 2018 | 1.58B | -73M | -4.42% |
| Jun 30, 2018 | 1.65B | 144M | +9.56% |
| Mar 31, 2018 | 1.51B | 143M | +10.49% |
| Dec 31, 2017 | 1.36B | 131M | +10.63% |
| Sep 30, 2017 | 1.23B | 56M | +4.76% |
| Jun 30, 2017 | 1.18B | 75M | +6.81% |
| Mar 31, 2017 | 1.1B | 153M | +16.14% |
| Dec 31, 2016 | 948M | 64M | +7.24% |
| Sep 30, 2016 | 884M | 107M | +13.77% |
| Jun 30, 2016 | 777M | 43M | +5.86% |
| Mar 31, 2016 | 734M | 132M | +21.93% |
| Dec 31, 2015 | 602M | 136M | +29.18% |
| Sep 30, 2015 | 466M | 29M | +6.64% |
| Jun 30, 2015 | 437M | 82M | +23.10% |
| Mar 31, 2015 | 355M | 74M | +26.33% |
| Dec 31, 2014 | 281M | 65M | +30.09% |
| Sep 30, 2014 | 216M | 45M | +26.32% |
| Jun 30, 2014 | 171M | 65M | +61.32% |
| Mar 31, 2014 | 106M | -28M | -20.90% |
| Dec 31, 2013 | 134M | -241M | -64.27% |
| Sep 30, 2013 | 375M | 363M | +3025.00% |
| Jun 30, 2013 | 12M | n/a | n/a |